Changes of related cytokine levels before and after minimally invasive total hip replacement

doi:10.3969/j.issn.2095-4344.0216

Abstract

Abstract:

BACKGROUND: Compared with conventional total hip replacement, minimally invasive total hip replacement has some advantages, such as small incision, less blood loss, light pain, low incidence of dislocation, and short rehabilitation period. However, changes in post-displacement stress and in vivo metabolism-related serological indicators have not been systematically reported.

OBJECTIVE: To observe cytokines and curative effect before and after minimally invasive total hip replacement and conventional total hip replacement.

METHODS: We selected 178 patients who underwent unilateral total hip replacement in the Department of Bone and Joint Surgery, Affiliated Hospital of Southwest Medical University from January 2015 to January 2017. They were randomly divided into observation group (89 cases) and control group (89 cases). The control group was treated by total hip arthroplasty through the standard invasive posterolateral approach. The observation group was treated by total hip arthroplasty through the minimally invasive anterolateral approach. The related operation indexes were recorded in two groups. Harris score was analyzed preoperatively, 1, 3, 6 and 12 months after surgery. The serum levels of interleukin (IL)-1, IL-6, IL-10, tumor necrosis factor (TNF)-α and procalcitonin were measured by enzyme linked immunosorbent assay preoperatively, 1 and 3 days after surgery.

RESULTS AND CONCLUSION: (1) All patients were followed up for 12 months. (2) Age, sex, body mass index and joint replacement site were not significantly different in both groups (P > 0.05). (3) The operation time, hospital stay and incision length in the observation group were shorter than those in the control group. The blood loss, blood transfusion, and postoperative drainage in the observation group were less than those in the control group (P < 0.05). (4) Harris Score increased at various time points after replacement in both groups. Harris score was significantly higher in the observation group than in the control group at 1 and 3 months after surgery (P < 0.05). (5) The serum levels of IL-1, IL-6, IL-10, TNF-α and procalcitonin in the observation group were significantly lower than in the control group 1 and 3 days after surgery. (6) These findings confirm that minimally invasive total hip arthroplasty has better curative effect than conventional total hip arthroplasty, and can reduce related cytokine levels, and is more conducive to the rapid recovery of lower extremity motor function.

中国组织工程研究杂志出版内容重点：人工关节；骨植入物；脊柱；骨折；内固定；数字化骨科；组织工程

Key words: Arthroplasty, Replacement, Hip, Surgical, Minimally Invasive, Tissue Engineering

CLC Number:

R318

Ma Chen-xi, Li Zhong. Changes of related cytokine levels before and after minimally invasive total hip replacement[J]. Chinese Journal of Tissue Engineering Research, 2018, 22(15): 2297-2302.

Figures/Tables 2

References

[1] 徐杰,庄伟达,李新炜,等. 直接前入路和后外侧保留梨状肌入路全髋关节置换术的疗效对比[J].北京大学学报(医学版)医学版, 2017, 49(2):214-220.

[2] Rolfson O, Bohm E, Franklin P, et al. Patient-reported outcome measures in arthroplasty registries.Acta Orthop. 2016; 87(Suppl 1): 9-23.

[3] Gordon M, Rysinska A, Garland A, et al. Increased long-term cardiovascular risk after total hip arthroplasty. Medicine (Baltimore). 2016; 95(6): e2662.

[4] Varnum C, Pedersen AB, Mäkelä K, et al. Increased risk of revision of cementless stemmed total hip arthroplasty with metal-on-metal bearings. Acta Orthop. 2015; 86(4): 491-497.

[5] 孙启才,茹选良,钱志钢,等.髋关节置换术治疗老年股骨转子间骨折内固定失败的中期随访[J]. 中国骨伤, 2017, 30(7): 591-596.

[6] 朱先洋,尹宗生,陈迪嘉.髋关节置换术后翻修原因及疗效分析[J].安徽医药,2017, 21(3):525-528.

[7] Yang BH, Li HP, He XJ, et al. Minimally invasive surgical approaches and traditional total hip arthroplasty: a meta-analysis of radiological and complications outcomes. PLoS One. 2012; 7(5): e37947.

[8] 艾芳,高辉,何春耒.前侧入路微创髋关节置换术快速康复护理.赣南医学院学报, 2017,37(1):30-31.

[9] 高辉,叶山山,何春耒,等.直接前侧入路微创全髋关节置换术中股外侧皮神经损伤的研究进展.中华解剖与临床杂志, 2017,22(3): 248-251.

[10] Poitras S, Wood KS, Savard J, et al. Predicting early clinical function after hip or knee arthroplasty. Bone Joint Res. 2015; 4(9):145-151.

[11] 周一新.骨科标准新突破手术技术指导规范《人工髋、膝关节置换术》解读[J].中国卫生标准管理,2011,2(04):72-74.

[12] 王本杰,赵德伟,谢辉,等.骨水泥型和生物型股骨假体半髋置换修复高龄股骨颈骨折[J].中国组织工程研究, 2015, 19(9): 1345-1351.

[13] 李华. Harris评分法与X射线评分法在全髋关节置换术疗效评价的比较[J]. 医学信息旬刊, 2010, 23(5):1334-1335.

[14] Berger RA, Jacobs JJ, Meneghini RM, et al. Rapid rehabilitation and recovery with minimally invasive total hip arthroplasty. Clin Orthop Relat Res. 2004; 429:239.

[15] Husted H. Fast-track hip and knee arthroplasty: clinical and organizational aspects. Lancet.2013;381(9878):1600-1602.

[16] Nakamura S, Matsuda K, Arai N, et al. Mini-incision posterior approach for total hip arthroplasty. Int Orthop. 2004; 28(4): 214-217.

[17] Smith TO, Blake V, Hing CB. Minimally invasive versus conventional exposure for total hip arthroplasty: a systematic review and meta-analysis of clinical and radiological outcomes. Int Orthop. 2011;35(2):173-184.

[18] Mclaughlin JR, Lee KR. Total hip arthroplasty with an uncemented tapered femoral component in patients younger than 50 years of age: a minimum 20-year follow-up study. J Bone Joint Surg Br. 2016; 31(6):1275-1278.

[19] Hallab NJ, Cunningham BW, Jacobs JJ. Spinal implant debris-induced osteolysis. Spine. 2003; 28(20):S125-138.

[20] Singh P, Castillo A, Majid DSA. Decrease in IL-10 and increase in TNF-α levels in renal tissues during systemic inhibition of nitric oxide in anesthetized mice. Physiol Rep.2014;2(2): e00228．

[21] Grassmé H, Gulbins E. CD95/CD95 ligand interactions on epithelial cells in host defense to Pseudomonas aeruginosa. Science. 2000;290(5491):527-530.

[22] Knoferl MW, Angele MK, Catania RA, et al. Immunomodulatory effects of dehydroepiandrosterone in proestrus female mice after trauma-hemorrhage. J Appl Physiol.2003,;95(2):529-535.

[23] Wakefield TW, Henke PK. The role of inflammation in early and late venous thrombosis: Are there clinical implications. Semin Vasc Surg. 2005; 18(3):118-129.

[24] Mocellin S, Marincola FM, Young HA. Interleukin-10 and the immune response against cancer: a counterpoint. J Leukoc Biol. 2005; 78(5):1043-1051.

[25] Yuan K, Li WD, Qiang Y, et al. Comparison of procalcitonin and C-reactive protein for the diagnosis of periprosthetic joint infection before revision total hip arthroplasty. Surg Infect (Larchmt).2015;16(2):146-150.

[26] Wunder C, Eichelbrönner O, Roewer N. Are IL-6, IL-10 and PCT plasma concentrations reliable for outcome prediction in severe sepsis? A comparison with APACHE III and SAPS II. Inflamm Res. 2004;53(4):158-163.

[27] Chang YL, Chen TH, Wu YH, et al. A novel TLR2-triggered signalling crosstalk synergistically intensifies TNF-mediated IL-6 induction. J Cell Mol Med. 2014;18(7):1344-57.

[28] Thomas H, Marcel K, Zorn CN, et al. Activation of the PI3K pathway increases TLR-induced TNF-α and IL-6 but reduces IL-1β production in mast cells. Cell Signal. 2011; 23(5): 866-875.

[29] Haimovich B, Reddell MT, Calvano J E, et al. A novel model of common Toll-like receptor 4- and injury-induced transcriptional themes in human leukocytes. Crit Care. 2010; 14(5):177-186.

[30] Das MA, Panda SK, Pradhan AK, et al. Filarial antigens mediate apoptosis of human monocytes through Toll-like receptor 4. J Infect Dis. 2014; 210(7):1133-1144.

[31] Babu S, Bhat SQ, Kumar NP, et al. Attenuation of toll-like receptor expression and function in latent tuberculosis by coexistent filarial infection with restoration following antifilarial chemotherapy. PLoS Negl Trop Dis. 2009; 3(7):e489-497.

[32] Larsen JM, Benn C S, Fillie Y, et al. BCG stimulated dendritic cells induce an interleukin-10 producing T-cell population with no T helper 1 or T helper 2 bias in vitro. Immunology. 2007; 121(2):276–282.